Thursday, 19 September 2019

Pharma News

  • Multiple organzations join hands to curb fake drug business

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: US Pharmacopeial Convention (USP) is gearing up its efforts to combat fake medicine circulating in the market and has joined hands with 11 new organizations to strengthen its glo...Read more

  • FDA approves Eisai's Fycompa

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Eisai announced that its U.S. subsidiary has received approval from the U.S. Food and Drug Administration (FDA) for the AMPA receptor antagonist Fycompa® (perampanel) as an adj...Read more

  • First-of-its-kind osteoarthritis study done in India

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 21 Sep, 2012

    Bangalore: Signaling relief to over 15 million knee-osteoarthritis patients in India, the world's first study "Osteoarthritis Synvisc One Indian Post Marketing Study" (OASIS) has revealed ...Read more

  • Novartis liver cancer trial with Afinitor flops

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 09 Aug, 2013

    Singapore: Novartis highlighted that the results of a global phase III study showed that Afinitor (everolimus) did not extend overall survival as compared to placebo in patients with locall...Read more

  • Oramed submits pre-IND for exenatide to FDA

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

    Singapore: Oramed Pharmaceuticals, a developer of oral drug delivery systems, submitted a pre-Investigational New Drug (pre-IND) meeting request to the US FDA for a US-based trial on its or...Read more

  • Alexion to acquire Synageva biopharma for $8.4 bn deal

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 07 May, 2015

    Singapore: Alexion pharmaceuticals recently announced the acquisition of Synageva Biopharma for $8.4 billion. US-based Synageva is a biopharmaceutical company dedicated to discovering, deve...Read more

  • Director resigns at China Nepstar Chain Drugstore

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Mr. Gary Siu Kwan Sik has resigned as an independent director of China Nepstar Chain Drugstore, the largest drugstore chain in China based on the number of directly operated stor...Read more

  • DKSH expands in Hong Kong

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 12 Nov, 2012

    Singapore: DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia, has signed an agreement with Nong's, traditonal chinese medicine...Read more

  • Innovative dual chamber syringe for pharma market

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jun, 2012

    Singapore: Japan-based Arte and German company ProJect Pharmaceutics are working closely on the development of a new type of dual chamber prefillable syringe for freeze-dried pharmaceutical...Read more

  • Indian FIPB clears pharma FDI proposals worth $536 mn

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 27 Aug, 2012

    New Delhi: The Indian Foreign Investment Promotion Board (FIPB), which is the foreign investment approval authority, has cleared eight of the ten pending proposals of foreign drug firms tha...Read more

  • Arvind sets up $42.37 mn plant top tap US market

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: Indian pharmaceutical firm, Arvind Remedies has been gearing up to take the US market by storm. The company has invested $42.37 million to set up a new manufacturing facility at ...Read more

  • Agnitio expands in China

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Agnitio, a leader in healthcare sector closed-loop marketing technology, continues to expand its global presence with the opening of regional headquarters in Shanghai and a part...Read more

  • Takeda to acquire LigoCyte Pharma

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Takeda Pharmaceutical Company and LigoCyte Pharmaceuticals, jointly announced that Takeda's wholly-owned subsidiary, Takeda America Holdings and LigoCyte Pharmaceuticals have en...Read more

  • Ranbaxy, Gilead sign licensing agreement

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 03 Aug, 2012

    New Delhi: Ranbaxy Laboratories has entered into an in-licensing agreement with Gilead Sciences to promote access to high-quality, low-cost generic versions of Gilead's HIV medicine emtrici...Read more

  • Universities get $15mn from Teva for CNS R&D

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2013

    Singapore: Israel-based Teva is undergoing re-organization in order to mitigate lost revenue from increased competition from copies of its best-selling branded multiple sclerosis drug, Copa...Read more

  • NSF brings Secondary Reference Standards to India

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: NSF International, an independent global public health and safety organization which develops standards, and tests and certifies products for the pharmaceutical, dietary suppleme...Read more

  • Takeda, Resolve to develop, sell autoimmune drugs

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 28 Feb, 2013

    Singapore: Takeda Pharmaceutical has entered into a partnership with Resolve Therapeutics to develop compounds for the treatment of lupus (also known as systemic lupus erythematosus or SLE)...Read more

  • Bayer initiates Phase II/III trial of a new compound for Hemophilia A

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore, July 09, 2012: Bayer HealthCare has started to enroll patients in an international Phase II/III trial to evaluate its investigational compound BAY94-9027 for the treatment of hem...Read more



Podcast

 

Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls